Ultrasound-Enhancing Agents and Associated Adverse Reactions: A Potential Connection to the COVID-19 Vaccines?
J Am Soc Echocardiogr
.
2022 Feb;35(2):241-242.
doi: 10.1016/j.echo.2021.09.014.
Epub 2021 Oct 7.
Authors
Meshal Soni
1
,
Michelle McGovern
1
,
Ron Jacob
2
,
Richard Weiss
3
,
Srinath Adusumalli
1
,
Sheldon Litwin
4
,
Dinesh Jagasia
1
,
Marielle Scherrer-Crosbie
1
Affiliations
1
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
2
Lancaster General Hospital, Lancaster, Pennsylvania.
3
Penn Presbyterian Hospital, Philadelphia, Pennsylvania.
4
Medical University of South Carolina, Charleston, South Carolina.
PMID:
34627975
PMCID:
PMC8496919
DOI:
10.1016/j.echo.2021.09.014
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines*
COVID-19*
Humans
SARS-CoV-2
Ultrasonography
Substances
COVID-19 Vaccines